CAPRICOR THERAPEUTICS, INC. Impairment of Intangible Assets, Finite-lived
CAPRICOR THERAPEUTICS, INC. (CAPR) reported Impairment of Intangible Assets, Finite-lived of $106.83 thousand for the 98-month period ending 2013-09-30, per its 10-Q filed 2013-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsFinitelived · last filed 2013-11-14
- CAPRICOR THERAPEUTICS, INC. impairment of intangible assets, finite-lived for the quarter ending 2013-09-30 was $0.00.
- CAPRICOR THERAPEUTICS, INC. impairment of intangible assets, finite-lived for the quarter ending 2013-06-30 was $0.00.
- CAPRICOR THERAPEUTICS, INC. impairment of intangible assets, finite-lived for the quarter ending 2013-03-31 was $0.00.
- CAPRICOR THERAPEUTICS, INC. impairment of intangible assets, finite-lived for the quarter ending 2012-12-31 was $0.00.
- CAPRICOR THERAPEUTICS, INC. impairment of intangible assets, finite-lived for fiscal 2012 was $0.00.
- CAPRICOR THERAPEUTICS, INC. impairment of intangible assets, finite-lived for fiscal 2011 was $0.00, a 100.00% decline from fiscal 2010.
- CAPRICOR THERAPEUTICS, INC. impairment of intangible assets, finite-lived for fiscal 2010 was $106.83K.
| Period end | Impairment of Intangible Assets, Finite-lived 3 month | Impairment of Intangible Assets, Finite-lived 6 month | Impairment of Intangible Assets, Finite-lived 9 month | Impairment of Intangible Assets, Finite-lived 12 month | Impairment of Intangible Assets, Finite-lived 71 month | Impairment of Intangible Assets, Finite-lived 74 month | Impairment of Intangible Assets, Finite-lived 77 month | Impairment of Intangible Assets, Finite-lived 80 month | Impairment of Intangible Assets, Finite-lived 83 month | Impairment of Intangible Assets, Finite-lived 86 month | Impairment of Intangible Assets, Finite-lived 89 month | Impairment of Intangible Assets, Finite-lived 92 month | Impairment of Intangible Assets, Finite-lived 95 month | Impairment of Intangible Assets, Finite-lived 98 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $0.00 derived: sum of 2 quarters · filed 2013-11-14 | $0.00 10-Q · filed 2013-11-14 | $0.00 derived: sum of 4 quarters · filed 2013-11-14 | $106.83K 10-Q · filed 2013-11-14 | |||||||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $0.00 10-Q · filed 2013-08-14 | $0.00 derived: sum of 3 quarters · filed 2013-08-14 | $0.00 derived: sum of 4 quarters · filed 2013-11-14 | $106.83K 10-Q · filed 2013-08-14 | |||||||||
| 2013-03-31 | $0.00 10-Q · filed 2013-06-21 | $0.00 derived: sum of 2 quarters · filed 2013-06-21 | $0.00 derived: sum of 3 quarters · filed 2013-11-14 | $0.00 derived: sum of 4 quarters · filed 2013-11-14 | $106.83K 10-Q · filed 2013-06-21 | |||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-21 | $0.00 derived: sum of 2 quarters · filed 2013-11-14 | $0.00 derived: sum of 3 quarters · filed 2013-11-14 | $0.00 10-K · filed 2013-06-21 | $106.83K 10-K · filed 2013-06-21 | |||||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $0.00 derived: sum of 2 quarters · filed 2013-11-14 | $0.00 10-Q · filed 2013-11-14 | $0.00 derived: sum of 4 quarters · filed 2013-11-14 | $106.83K 10-Q · filed 2013-06-21 | |||||||||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $0.00 10-Q · filed 2013-08-14 | $0.00 derived: sum of 3 quarters · filed 2013-08-14 | $106.83K 10-Q/A · filed 2012-09-10 | ||||||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-06-21 | $0.00 derived: sum of 2 quarters · filed 2013-06-21 | $106.83K 10-Q/A · filed 2012-05-15 | |||||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-21 | $0.00 10-K · filed 2013-06-21 | $106.83K 10-K · filed 2012-04-02 | |||||||||||
| 2011-09-30 | $0.00 10-Q · filed 2013-06-21 | $106.83K 10-Q · filed 2011-11-14 | ||||||||||||
| 2011-06-30 | $106.83K 10-Q · filed 2011-08-15 | |||||||||||||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-02 | $0.00 derived: sum of 2 quarters · filed 2012-04-02 | $106.83K 10-K · filed 2012-04-02 | |||||||||||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $106.83K 10-Q · filed 2011-11-14 | ||||||||||||
| 2010-06-30 | $106.83K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |